Role of ocular cytology in vernal keratoconjunctivitis

Children with vernal keratoconjunctivitis (VKC) present symptoms that are similar to other ocular allergies, but more pronounced, and are controlled using topical steroids. To avoid excessive and prolonged use of topical steroid eye drops, over the past 20 years galenic eye drops of cyclosporine with a concentration of 1% to 2% and tacrolimus with a concentration of 0.1% have been introduced as a treatment for the severe and unresponsive forms. The main symptoms of VKC occur most frequently during the spring and tend to get worse during the summer, meaning that affected children tend to avoid exposure to sunlight. The aim of this study was to assess the most common cell types present in the conjunctiva of children with VKC, how ocular treatment can influence them, and whether affected children express a typical conjunctival pattern, which could be useful as a pathognomonic pattern of VKC, allowing us to study this rare eye disease.

[1]  Mulusew A Asferaw,et al.  Prevalence and associated factors of vernal keratoconjunctivitis among children in Gondar city, Northwest Ethiopia , 2016, BMC Ophthalmology.

[2]  G. Passalacqua,et al.  NASAL cytology: practical aspects and clinical relevance , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  A. Murakami,et al.  Vernal Keratoconjunctivitis With Giant Papillae on the Inferior Tarsal Conjunctiva , 2014, Cornea.

[4]  A. Leonardi.  Allergy and allergic mediators in tears. , 2013, Experimental eye research.

[5]  Pietro Fanelli,et al.  Utilità della citologia congiuntivale nella diagnosi e nel monitoraggio terapeutico della cheratocongiuntivite Vernal , 2013 .

[6]  Sunil Kumar.  Vernal keratoconjunctivitis: a major review , 2009, Acta ophthalmologica.

[7]  S. Aymé,et al.  Prevalence of vernal keratoconjunctivitis: a rare disease? , 2008, British Journal of Ophthalmology.

[8]  F. Mantelli,et al.  Clinical grading of vernal keratoconjunctivitis , 2007, Current opinion in allergy and clinical immunology.

[9]  F. Cardinale,et al.  Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[10]  M. Plebani,et al.  Th1- and Th2-type cytokines in chronic ocular allergy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  E. Novembre,et al.  Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  A. Leonardi.  Vernal keratoconjunctivitis: pathogenesis and treatment , 2002, Progress in Retinal and Eye Research.

[13]  P. Pasqualetti,et al.  Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. , 2000, Ophthalmology.

[14]  A. Leonardi,et al.  Pathophysiology of allergic conjunctivitis. , 1999, Acta ophthalmologica Scandinavica. Supplement.

[15]  Calder,et al.  Cytokine production and mRNA expression by conjunctival T‐cell lines in chronic allergic eye disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  L. M. Collum.  Vernal keratoconjunctivitis. , 1999, Acta ophthalmologica Scandinavica. Supplement.

[17]  E. Takamura,et al.  Detection by Brush Cytology of Mast Cells and Eosinophils in Allergic and Vernal Conjunctivitis , 1991, Cornea.

[18]  M. Abelson,et al.  Conjunctival eosinophils in allergic ocular disease. , 1983, Archives of ophthalmology.